颈丛神经阻滞疗法中国专家共识(2020版)

2020-08-30 中国临床麻醉/疼痛相关专家组(统称) 中华疼痛学杂志.2020.16(4):243-255.

颈丛神经阻滞疗法是疼痛科基本的治疗方法,主要适用于头颈肩部疼痛的治疗,及某些手术的局部麻醉。本专家共识介绍了颈部和颈丛神经解剖,系统描述了颈丛神经阻滞疗法的各种操作方法、常用药物、适应证和并发症。本专

中文标题:

颈丛神经阻滞疗法中国专家共识(2020版)

发布日期:

2020-08-30

简要介绍:

颈丛神经阻滞疗法是疼痛科基本的治疗方法,主要适用于头颈肩部疼痛的治疗,及某些手术的局部麻醉。本专家共识介绍了颈部和颈丛神经解剖,系统描述了颈丛神经阻滞疗法的各种操作方法、常用药物、适应证和并发症。本专家共识推荐使用解剖定位法和影像引导下进行颈丛神经阻滞。文献和临床应用证实,颈丛神经阻滞疗法是头颈肩部慢性疼痛性疾病的一种安全、有效的诊断和治疗方法。

 

下载附件:

(因为版权问题,不支持下载)

评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1008718, encodeId=d2241008e1890, content=棒棒棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff25575336, createdName=ms1000001256854968, createdTime=Tue Aug 17 14:36:51 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974505, encodeId=d0889e45057b, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/0922a5df24904e4f86d563d49079aa1d/bf4a0e7be5fb4e7892ff94a8306fe9b7.jpg, createdBy=fc9b4705948, createdName=麻无赦, createdTime=Thu Jun 17 22:08:44 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972788, encodeId=6ad59e27888c, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec605518179, createdName=ms9000001320544995, createdTime=Fri Jun 11 10:43:20 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971475, encodeId=8d129e147505, content=非常需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ade45515163, createdName=小华药学, createdTime=Mon Jun 07 10:48:50 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918554, encodeId=f219918554e1, content=非常需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7aa5453124, createdName=nvc0520, createdTime=Wed Jan 20 21:49:32 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
    2021-08-17 ms1000001256854968

    棒棒棒

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1008718, encodeId=d2241008e1890, content=棒棒棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff25575336, createdName=ms1000001256854968, createdTime=Tue Aug 17 14:36:51 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974505, encodeId=d0889e45057b, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/0922a5df24904e4f86d563d49079aa1d/bf4a0e7be5fb4e7892ff94a8306fe9b7.jpg, createdBy=fc9b4705948, createdName=麻无赦, createdTime=Thu Jun 17 22:08:44 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972788, encodeId=6ad59e27888c, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec605518179, createdName=ms9000001320544995, createdTime=Fri Jun 11 10:43:20 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971475, encodeId=8d129e147505, content=非常需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ade45515163, createdName=小华药学, createdTime=Mon Jun 07 10:48:50 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918554, encodeId=f219918554e1, content=非常需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7aa5453124, createdName=nvc0520, createdTime=Wed Jan 20 21:49:32 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
    2021-06-17 麻无赦

    好文

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1008718, encodeId=d2241008e1890, content=棒棒棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff25575336, createdName=ms1000001256854968, createdTime=Tue Aug 17 14:36:51 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974505, encodeId=d0889e45057b, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/0922a5df24904e4f86d563d49079aa1d/bf4a0e7be5fb4e7892ff94a8306fe9b7.jpg, createdBy=fc9b4705948, createdName=麻无赦, createdTime=Thu Jun 17 22:08:44 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972788, encodeId=6ad59e27888c, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec605518179, createdName=ms9000001320544995, createdTime=Fri Jun 11 10:43:20 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971475, encodeId=8d129e147505, content=非常需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ade45515163, createdName=小华药学, createdTime=Mon Jun 07 10:48:50 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918554, encodeId=f219918554e1, content=非常需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7aa5453124, createdName=nvc0520, createdTime=Wed Jan 20 21:49:32 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
    2021-06-11 ms9000001320544995

    谢谢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1008718, encodeId=d2241008e1890, content=棒棒棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff25575336, createdName=ms1000001256854968, createdTime=Tue Aug 17 14:36:51 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974505, encodeId=d0889e45057b, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/0922a5df24904e4f86d563d49079aa1d/bf4a0e7be5fb4e7892ff94a8306fe9b7.jpg, createdBy=fc9b4705948, createdName=麻无赦, createdTime=Thu Jun 17 22:08:44 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972788, encodeId=6ad59e27888c, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec605518179, createdName=ms9000001320544995, createdTime=Fri Jun 11 10:43:20 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971475, encodeId=8d129e147505, content=非常需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ade45515163, createdName=小华药学, createdTime=Mon Jun 07 10:48:50 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918554, encodeId=f219918554e1, content=非常需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7aa5453124, createdName=nvc0520, createdTime=Wed Jan 20 21:49:32 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
    2021-06-07 小华药学

    非常需要

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1008718, encodeId=d2241008e1890, content=棒棒棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff25575336, createdName=ms1000001256854968, createdTime=Tue Aug 17 14:36:51 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974505, encodeId=d0889e45057b, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/0922a5df24904e4f86d563d49079aa1d/bf4a0e7be5fb4e7892ff94a8306fe9b7.jpg, createdBy=fc9b4705948, createdName=麻无赦, createdTime=Thu Jun 17 22:08:44 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972788, encodeId=6ad59e27888c, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec605518179, createdName=ms9000001320544995, createdTime=Fri Jun 11 10:43:20 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971475, encodeId=8d129e147505, content=非常需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ade45515163, createdName=小华药学, createdTime=Mon Jun 07 10:48:50 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918554, encodeId=f219918554e1, content=非常需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7aa5453124, createdName=nvc0520, createdTime=Wed Jan 20 21:49:32 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
    2021-01-20 nvc0520

    非常需要

    0